UK AstraZeneca recipients die of clots; regulator: Benefits outweigh risks

Australia probes if blood clot case linked to AstraZeneca vaccine

He said: "It's also important to recognise that one thing the coronavirus does is it really increases your risk of developing blood clots so in terms of risk and benefits the vaccine is a safe vaccine".

The MHRA's chief executive, Dr June Raine, said: "The benefits of COVID-19 Vaccine AstraZeneca in preventing COVID-19 infection and its complications continue to outweigh any risks and the public should continue to get their vaccine when invited to do so". He added that doctors and people who had received the AstraZeneca vaccine should be on the lookout for symptoms of the clotting events, like severe headaches or signs of a stroke.

That view is echoed by the World Health Organisation (WHO), which has urged countries to continue using the jab. "The implication of that is many more people are getting COVID-19 and potentially dying".

The European Medicines Agency is expected to update its recommendation on this issue on April 7.

Last week, Britain announced a third coronavirus vaccine from United States firm Moderna (MRNA) will be rolled out in the United Kingdom from April and will join the AstraZeneca and Pfizer (PFE)/ BioNtech (BNTX) jabs already being offered on the NHS.

David Werring, a professor at University College London's Institute of Neurology, said that the unusual presentation of the cases in vaccinated people was creating concern about possible links with the shot.


Both the EMA and the National Public Health Emergency Team (NPHET) recommended that the use of the vaccine in Ireland should continue after a conclusion by the former that the vaccine is "safe and effective" following fears last month.

Adam Finn, a professor of pediatrics at the University of Bristol, said the "extreme rarity" of the blood-clotting events in the context of the millions of jabs administered in the United Kingdom makes the decision very straightforward.

A more detailed look at the MHRA's findings shows that of the 30 cases, 22 related to cerebral venous sinus thrombosis, which stops blood draining from the brain properly, and eight were connected with other thrombosis events with low platelets.

The same lawyer is also representing the family of a French medical student who died days after he received AstraZeneca's Covid-19 vaccine in the western city of Nantes.

The Therapeutic Goods Administration (TGA) regulator and a panel, the Australian Technical Advisory Group on Immunisation (ATAGI), met late Friday and early Saturday to discuss further advice on the AstraZeneca vaccine.

The Minister wrote in a letter to Parliament that he took this decision pending a further judgment by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. People can not choose which one they get. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.

Related:

Comments

Latest news

PACK YOUR BAGS: Restrictions Loosened For Fully-Vaccinated Travelers
The United States continues to make progress in Covid-19 vaccinations, with 50 percent of Americans 65 and older fully vaccinated. According to the health authorities, the pandemic causes an average of about 1,000 deaths per day in the United States.

Americans with 2 COVID vaccine doses can travel, CDC says
The firms said that of these cases, 850 occurred among participants who got the placebo, while 77 were in the vaccinated group. A BLA is an application for full approval.

Rebel group says more than 12,000 displaced by Myanmar junta air strikes
About 3,000 Karen villagers have fled to neighboring Thailand in recent days, but many have returned under unclear circumstances. In another escalation, since Saturday the military has launched regular air strikes targeting the KNU in eastern Karen state.

Biden Hails March Jobs Numbers As Source Of 'Hope'
Areas like movie theaters and hotels still have a long way to go, as they continue to lag in recovery . The benefits and the impact the American Rescue Plan are temporary by design.

People under 60 should not get 2nd AstraZeneca vaccine: German experts
The organisation said in the period when the five cases were reported, some 400,000 people were vaccinated in the Netherlands with the AstraZeneca shot.

Other news